King Charles III’s cancer was “caught early,” U.K. Prime Minister Rishi Sunak says

King Charles III’s cancer was “caught early,” U.K. Prime Minister Rishi Sunak says

Doctors have detected cancer in Britain’s King Charles III, Buckingham Palace said in a statement Monday. The unspecified cancer was discovered as doctors treated the monarch for an enlarged prostate just over a week ago. British Prime Minister Rishi Sunak told CBS News partner network BBC News Tuesday that Charles’ cancer was “caught early.” Sunak … Read more

Britain’s King Charles III admitted to hospital for scheduled enlarged prostate treatment

Britain’s King Charles III admitted to hospital for scheduled enlarged prostate treatment

Britain’s King Charles III was admitted Friday to a private London hospital for scheduled treatment for an enlarged prostate, which Buckingham Palace announced last week he would be undergoing. The palace has said his condition is benign, and on Friday it said the monarch was “delighted to learn that his diagnosis is having a positive impact … Read more

Princess Kate surgery announcement leaves questions, but here’s what we know

Princess Kate surgery announcement leaves questions, but here’s what we know

London — At their most recent public outing, attending the annual Christmas Day church service in Sandringham, England, Britain’s King Charles III and his daughter-in-law Princess Catherine were the picture of health. So, the twin announcements Wednesday that the future queen was already in a private London clinic recovering from abdominal surgery and the monarch is … Read more

USFDA gives tentative approval to Lupin’s prostate cancer tablets – Pharma News

USFDA gives tentative approval to Lupin’s prostate cancer tablets – Pharma News

Global pharma major Lupin Limited recently announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Apalutamide Tablets, 60 mg. Approval is granted to market a generic equivalent of Erleada Tablets, 60 mg of Janssen Biotech, Inc. This product will be … Read more

New drugs have increased survival rates for men with metastatic prostate cancer

New drugs have increased survival rates for men with metastatic prostate cancer

Survival rates for men with metastatic prostate cancer have increased by an average of six months, something which coincides with the gradual introduction of ‘dual treatment’ since 2016. This is according to a register study of all Swedish men diagnosed between 2008 and 2020. The results are published in the medical journal JAMA Network Open. … Read more

Shorter course of radiation therapy just as effective for intermediate risk prostate cancer, study shows

Shorter course of radiation therapy just as effective for intermediate risk prostate cancer, study shows

People with intermediate risk, localized prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower doses delivered over several weeks, a new phase III randomized trial suggests. The findings, which are the latest from a series of studies investigating the … Read more

New consensus statement provides guidance for use of 177Lu-PSMA radionuclide therapy in mCRPC patients

New consensus statement provides guidance for use of 177Lu-PSMA radionuclide therapy in mCRPC patients

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a new consensus statement to provide standardized guidance for the selection and management of metastatic castrate-resistant prostate cancer (mCRPC) patients being treated with 177Lu-PSMA radionuclide therapy. The statement, published in the July issue of The Journal of Nuclear Medicine, also reviews current clinical struggles … Read more